Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00803
|
|||||
| Drug Name |
CX-4945
|
|||||
| Synonyms |
1009820-21-6; 5-((3-Chlorophenyl)amino)benzo-[c][2,6]naphthyridine-8-carboxylic acid; 5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid; 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid; 5-[(3-Chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-Carboxylic Acid; 5-[(3-chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid; AK-82006; C19H12ClN3O2; C6RWP0N0L2; CHEMBL1230165; CX 4945; CX-4945; CX-4945 (Silmitasertib); CX4945; Silmitasertib; UNII-C6RWP0N0L2; W-204393
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H12ClN3O2
|
|||||
| Canonical SMILES |
C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4
|
|||||
| InChI |
InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)
|
|||||
| InChIKey |
MUOKSQABCJCOPU-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 349.8 | Topological Polar Surface Area | 75.1 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
4.4
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.